Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III diagnostic and safety comparison of C-Tb versus QuantiFERON-TB Gold In-Tube and PPD in subjects suspected of tuberculosis
2011-005078-40Phase 3
- Sponsor
- Statens Serum Institut
- Start
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of C-Tb in Tuberculosis (TB) (2 arms), sponsored by Statens Serum Institut. Primary endpoint: C-Tb induration diameter.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2011-005078-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005078-40.